Cargando…
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide
BackgroundEvidence suggests that the gut microbiota play an important role in gastrointestinal problems. AimTo give clinicians a practical reference guide on the role of specified probiotics in managing particular lower gastrointestinal symptoms/problems by means of a systematic review-based consens...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925990/ https://www.ncbi.nlm.nih.gov/pubmed/23981066 http://dx.doi.org/10.1111/apt.12460 |
_version_ | 1782303928405196800 |
---|---|
author | Hungin, A P S Mulligan, C Pot, B Whorwell, P Agréus, L Fracasso, P Lionis, C Mendive, J Philippart de Foy, J-M Rubin, G Winchester, C Wit, N |
author_facet | Hungin, A P S Mulligan, C Pot, B Whorwell, P Agréus, L Fracasso, P Lionis, C Mendive, J Philippart de Foy, J-M Rubin, G Winchester, C Wit, N |
author_sort | Hungin, A P S |
collection | PubMed |
description | BackgroundEvidence suggests that the gut microbiota play an important role in gastrointestinal problems. AimTo give clinicians a practical reference guide on the role of specified probiotics in managing particular lower gastrointestinal symptoms/problems by means of a systematic review-based consensus. MethodsSystematic literature searching identified randomised, placebo-controlled trials in adults; evidence for each symptom/problem was graded and statements developed (consensus process; 10-member panel). As results cannot be generalised between different probiotics, individual probiotics were identified for each statement. ResultsThirty seven studies were included; mostly on irritable bowel syndrome [IBS; 19 studies; treatment responder rates: 18–80% (specific probiotics), 5–50% (placebo)] or antibiotic-associated diarrhoea (AAD; 10 studies). Statements with 100% agreement and ‘high’ evidence levels indicated that: (i) specific probiotics help reduce overall symptom burden and abdominal pain in some IBS patients; (ii) in patients receiving antibiotics/Helicobacter pylori eradication therapy, specified probiotics are helpful as adjuvants to prevent/reduce the duration/intensity of AAD; (iii) probiotics have favourable safety in patients in primary care. Items with 70–100% agreement and ‘moderate’ evidence were: (i) specific probiotics help relieve overall symptom burden in some patients with diarrhoea-predominant IBS, and reduce bloating/distension and improve bowel movement frequency/consistency in some IBS patients and (ii) with some probiotics, improved symptoms have led to improvement in quality of life. ConclusionsSpecified probiotics can provide benefit in IBS and antibiotic-associated diarrhoea; relatively few studies in other indications suggested benefits warranting further research. This study provides practical guidance on which probiotic to select for a specific problem. |
format | Online Article Text |
id | pubmed-3925990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39259902014-02-21 Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide Hungin, A P S Mulligan, C Pot, B Whorwell, P Agréus, L Fracasso, P Lionis, C Mendive, J Philippart de Foy, J-M Rubin, G Winchester, C Wit, N Aliment Pharmacol Ther Systematic Reviews BackgroundEvidence suggests that the gut microbiota play an important role in gastrointestinal problems. AimTo give clinicians a practical reference guide on the role of specified probiotics in managing particular lower gastrointestinal symptoms/problems by means of a systematic review-based consensus. MethodsSystematic literature searching identified randomised, placebo-controlled trials in adults; evidence for each symptom/problem was graded and statements developed (consensus process; 10-member panel). As results cannot be generalised between different probiotics, individual probiotics were identified for each statement. ResultsThirty seven studies were included; mostly on irritable bowel syndrome [IBS; 19 studies; treatment responder rates: 18–80% (specific probiotics), 5–50% (placebo)] or antibiotic-associated diarrhoea (AAD; 10 studies). Statements with 100% agreement and ‘high’ evidence levels indicated that: (i) specific probiotics help reduce overall symptom burden and abdominal pain in some IBS patients; (ii) in patients receiving antibiotics/Helicobacter pylori eradication therapy, specified probiotics are helpful as adjuvants to prevent/reduce the duration/intensity of AAD; (iii) probiotics have favourable safety in patients in primary care. Items with 70–100% agreement and ‘moderate’ evidence were: (i) specific probiotics help relieve overall symptom burden in some patients with diarrhoea-predominant IBS, and reduce bloating/distension and improve bowel movement frequency/consistency in some IBS patients and (ii) with some probiotics, improved symptoms have led to improvement in quality of life. ConclusionsSpecified probiotics can provide benefit in IBS and antibiotic-associated diarrhoea; relatively few studies in other indications suggested benefits warranting further research. This study provides practical guidance on which probiotic to select for a specific problem. Blackwell Publishing Ltd 2013-10 2013-08-27 /pmc/articles/PMC3925990/ /pubmed/23981066 http://dx.doi.org/10.1111/apt.12460 Text en Copyright © 2013 John Wiley & Sons Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Systematic Reviews Hungin, A P S Mulligan, C Pot, B Whorwell, P Agréus, L Fracasso, P Lionis, C Mendive, J Philippart de Foy, J-M Rubin, G Winchester, C Wit, N Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide |
title | Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide |
title_full | Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide |
title_fullStr | Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide |
title_full_unstemmed | Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide |
title_short | Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide |
title_sort | systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide |
topic | Systematic Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925990/ https://www.ncbi.nlm.nih.gov/pubmed/23981066 http://dx.doi.org/10.1111/apt.12460 |
work_keys_str_mv | AT hunginaps systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT mulliganc systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT potb systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT whorwellp systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT agreusl systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT fracassop systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT lionisc systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT mendivej systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT philippartdefoyjm systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT rubing systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT winchesterc systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide AT witn systematicreviewprobioticsinthemanagementoflowergastrointestinalsymptomsinclinicalpracticeanevidencebasedinternationalguide |